Brimonidine recalls

The FDA has published 4 recalls involving Brimonidine since 2020. The latest was reported on 15 Mar 2023. Most were for foreign material. Somerset Therapeutics has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Mar 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 1 25%Class III 3 75%

Why brimonidine is recalled

By year

All brimonidine recalls, newest first

4 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIBrimonidine Tartrate Ophthalmic Solution recalled by ApotexBrimonidine TartrateApotexSterilityNationwide
DrugCLASS IIIBrimonidine Tartrate Opthalmic Solution recalledBrimonidine TartrateSomerset TherapeuticsForeign MaterialNationwide
DrugCLASS IIIBrimonidine Tartrate Opthalmic Solution recalledBrimonidine TartrateSomerset TherapeuticsForeign MaterialNationwide
DrugCLASS IIIBrimonidine Tartrate Opthalmic Solution recalledBrimonidine TartrateSomerset TherapeuticsForeign MaterialNationwide

Should you stop taking Brimonidine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.